SCHEMBL2560880

SCHEMBL2560880

CC1CCN(CCC=O)CC1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 1/20 0.50
PRMT6 Q96LA8 1/20 0.50
PRMT1 Q99873 1/20 0.50
PRMT8 Q9NR22 1/20 0.50
SIGMAR1 Q99720 9/20 0.47
HTT P42858 2/20 0.46
POLB P06746 1/20 0.46
ACHE P22303 3/20 0.43
HRH3 Q9Y5N1 3/20 0.43
MEN1 O00255 1/20 0.37
CHRM2 P08172 1/20 0.37
HTR1A P08908 1/20 0.37
ADRA2A P08913 1/20 0.37
DRD1 P21728 1/20 0.37
ADRA1A P35348 1/20 0.37
OPRM1 P35372 1/20 0.37
DRD3 P35462 1/20 0.37
KMT2A Q03164 1/20 0.37
KCNH2 Q12809 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5808106 0.88 SIGMAR1 (0.50) CARM1PRMT6PRMT1PRMT8SIGMAR1
SCHEMBL2560103 0.88 CARM1 (0.38) CARM1PRMT6PRMT1PRMT8SIGMAR1
SCHEMBL31124137 0.88 CARM1 (0.38) CARM1PRMT6PRMT1PRMT8SIGMAR1
SCHEMBL8971073 0.86 SIGMAR1 (0.46) CARM1PRMT6PRMT1PRMT8SIGMAR1
SCHEMBL2555396 0.79 GNAO1 (0.34) CARM1PRMT6PRMT1PRMT8SIGMAR1
SCHEMBL2558770 0.78 KCNA3 (0.41) SIGMAR1ACHEHRH3
SCHEMBL2558774 0.78 GNAI3 (0.46) SIGMAR1HTTPOLBHRH3
SCHEMBL12859352 0.78 CARM1 (0.50) CARM1PRMT6PRMT1PRMT8SIGMAR1
SCHEMBL5362273 0.78
SCHEMBL20234635 0.78 CARM1 (0.65) CARM1PRMT6PRMT1PRMT8SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-11225655-B2 Bi-functional complexes and methods for making and using such complexes NUEVOLUTION A/S (DK) 2022-01-18 US disclosed
EP-3540059-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES Nuevolution A/S (DK) 2019-09-18 EP disclosed
EP-2558577-B1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION AS (DK) 2018-12-12 EP disclosed
US-20130281324-A1 BI-FUNCTINAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2013-10-24 US disclosed
EP-2558577-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES Nuevolution A/S (DK) 2013-02-20 EP disclosed
WO-2011127933-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2011-10-20 WO disclosed
WO-2006093518-A2 THIENYL COMPOUNDS FOR TREATING VIRUS-RELATED CONDITIONS APATH, LLC (US) 2006-09-08 WO disclosed